The cachexia of malignancy is considered mediated through excess production of tumor necrosis factor–alpha and other cytokines. Thalidomide (Thalomid), a sedative/hypnotic, has been shown to inhibit tumor necrosis factor–alpha production.
J. Frost
Advertisement
Articles by J. Frost
Advertisement
Latest Updated Articles
- Thalidomide-Induced Cessation of Weight Loss and Improved Sleep in Advanced Cancer Patients With Cachexia
Published: November 1st 2000 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Amivantamab in EGFR+ NSCLC
2
Imlunestrant Combo Will Not Be Pursued for FDA Approval in Breast Cancer
3
FDA Grants Regular Approval to Rucaparib in Metastatic CRPC
4
Pelareorep Exhibits Activity in Second-Line KRAS-Mutated Metastatic CRC
5